Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: Immune Disorder HSCT Protocol [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on a hematopoietic stem cell transplant protocol for several inherited immune deficiency disorders; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Immune Deficiency Disorders, Severe Combined Immunodeficiency | Phase 2 | Status: ACTIVE_NOT_RECRUITING